Rare genetic disorder provides clues to development of the pancreas
12 December 2011
Pancreatic agenesis is a rare condition in which the body is unable to produce a pancreas. The pancreas plays an essential part in regulating levels of sugar (glucose) in the blood. It does this by the release of the hormone insulin, which is generated and released by cells known as pancreatic beta cells. It also produces enzymes to help digest and absorb food.
Rare mutations in the genes PDX1 and PTF1A have previously been shown to cause pancreatic agenesis but have only been identified in a handful of families affected by the condition. Until now, the underlying causes of most cases have been unknown.
In a paper published today in 'Nature Genetics', an international team of researchers led by scientists from the Peninsula College of Medicine and Dentistry at the University of Exeter report a mutation in the gene GATA6 found in 15 out of 27 individuals with pancreatic agenesis. The study, funded by organisations including the Wellcome Trust, Diabetes UK and the National Institute for Health Research, establishes a key role for GATA6 in the development of pancreatic cells.
The finding was particularly surprising because switching off the GATA6 gene in mouse models seemed to make no difference to the development of the pancreas.
Professor Andrew Hattersley from the Peninsula College of Medicine and Dentistry said: "This rare genetic condition has provided us with a surprising insight into how the pancreas develops. What is it that programmes cells to become pancreatic beta cells? Our study suggests that GATA6 plays a very important role in this process and we hope this will help the crucial work to try and make beta cells for patients with type 1 diabetes."
Whereas pancreatic agenesis is an extreme form of pancreatic dysfunction, diabetes is far more common. In type 1 diabetes (which generally develops in childhood), the immune system attacks and destroys pancreatic beta cells and the body is unable to regulate glucose levels; in type 2 diabetes, the beta cells gradually decline until - usually during adulthood - they cease to function.
Professor Sian Ellard, also from Peninsula College of Medicine and Dentistry, added: "This discovery was possible because new sequencing approaches meant we could test all the genetic information in one go and because with the help of doctors throughout the world we were able to study 27 patients with a very rare condition."
Image: Organelles in a pancreas cell. Credit: University of Edinburgh/Wellcome Images.
Senior Media Officer
T +44 (0)20 7611 7329
Notes for editors
Allen HL et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet 2011 (epub ahead of print).
About the Wellcome Trust
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust's breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests.